http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034812-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93768fad4f1b0a508e6ce80bf29e952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07187de6dfd790527f84f6f453dd4dc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89debf9357693402d645a30b36cd0cba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c94dcd338fd516ef7c00a780ebfb173
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12C11-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-04
filingDate 2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d0cf842eb5eeef01b669e182d7bcd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_822bd1bec3e69d8d3d7db4b6556bc754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db835b9d251df31985a1a6539b70649e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f41e5e16f7d23814d4c74d7a42ec2a9
publicationDate 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006034812-A2
titleOfInvention Method for producing an optically active 2-methyl-alkane-1-ol from the corresponding 2-methylalk-2-en-1-al, comprising carbonyl-selective reduction, enantioselective hydration and lipase-catalyzed, stereoselective acylation in order to enrich the desired enantiomer
abstract The invention relates to a method for producing optically active 2-methylalkane-1-ol of general formula (III), comprising the following steps: (i) carbonyl-selective reduction of 2-methylalk-2-en-1-al of general formula (I) to 2-methylalk-2-en-1-ol of general formula (II), (ii) enantioselective hydration of 2-methylalk-2-en-1-ol to give the compound of general formula (III), (iii) increasing the optical yield of the optically active 2-methylalkane-1-ol (III) obtained in step (ii) by way of a lipase-catalyzed acylation reaction, whereby R represents C<sub
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010126448-A
priorityDate 2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0529698-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0492401-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129218265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91549705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248877674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87212113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54126640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128386932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128209698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6999993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6993810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128833797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10192564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227437292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129082194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87212138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127899422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227437867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227016181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14383762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129180685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227436839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231418865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20549468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128151118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127971320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227002341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66781198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227437866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227438163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128908727

Total number of triples: 76.